• Table of Contents

  • Injectable Turinabol as an Alternative to Oral Intake in Sports
  • The Pharmacology of Injectable Turinabol
  • The Benefits of Injectable Turinabol in Sports
  • Real-World Examples
  • Expert Opinion
  • Conclusion
  • References

Injectable Turinabol as an Alternative to Oral Intake in Sports

Performance-enhancing drugs have been a controversial topic in the world of sports for decades. Athletes are constantly seeking ways to improve their performance and gain a competitive edge, and the use of these drugs has become increasingly prevalent. One such drug that has gained attention in recent years is turinabol, a synthetic anabolic androgenic steroid. While it is commonly taken orally, there is growing interest in its injectable form as an alternative. In this article, we will explore the use of injectable turinabol in sports and its potential benefits.

The Pharmacology of Injectable Turinabol

Turinabol, also known as chlorodehydromethyltestosterone, was first developed in the 1960s by East German scientists as a performance-enhancing drug for their Olympic athletes. It is a modified form of testosterone, with an added chlorine atom at the fourth carbon position. This modification makes it more resistant to metabolism and increases its anabolic properties, while reducing its androgenic effects (Kicman & Gower, 2003).

When taken orally, turinabol is rapidly absorbed and metabolized by the liver, resulting in a short half-life of approximately 16 hours (Schänzer et al., 1996). This can lead to fluctuations in blood levels and potentially cause liver toxicity. However, when administered via injection, the drug bypasses the liver and is directly absorbed into the bloodstream, resulting in a longer half-life and more stable blood levels (Kicman & Gower, 2003).

The pharmacokinetics of injectable turinabol have been studied in both animals and humans. In a study on rats, it was found that the drug had a half-life of 48 hours when injected intramuscularly (Schänzer et al., 1996). In humans, a single intramuscular injection of 100mg resulted in peak blood levels after 24 hours, with levels remaining elevated for up to 7 days (Kicman & Gower, 2003). This prolonged release of the drug can provide a more sustained anabolic effect compared to oral intake.

The Benefits of Injectable Turinabol in Sports

The use of turinabol in sports is primarily for its anabolic effects, which can lead to increased muscle mass, strength, and endurance. However, the oral form of the drug has been associated with liver toxicity and other adverse effects, making injectable turinabol a more attractive option for athletes.

One of the main benefits of injectable turinabol is its longer half-life and more stable blood levels. This can result in a more sustained anabolic effect, allowing athletes to maintain their performance over a longer period. It also reduces the risk of liver toxicity, as the drug does not have to pass through the liver for metabolism.

Another advantage of injectable turinabol is its potential for lower doses compared to the oral form. Studies have shown that a single intramuscular injection of 100mg can result in peak blood levels similar to those achieved with a daily oral dose of 40mg (Kicman & Gower, 2003). This can reduce the risk of adverse effects and make it a more manageable option for athletes.

Furthermore, the injectable form of turinabol may have a lower potential for detection in drug tests compared to the oral form. This is due to the longer half-life and more stable blood levels, which can make it more difficult to detect in urine samples (Kicman & Gower, 2003). While this is not a guarantee, it may be a consideration for athletes who are subject to drug testing.

Real-World Examples

The use of injectable turinabol in sports is not a new concept. In fact, it has been reported that the East German Olympic team used the injectable form of the drug in the 1970s and 1980s, with great success (Kicman & Gower, 2003). More recently, there have been reports of athletes in various sports, including bodybuilding and mixed martial arts, using injectable turinabol as part of their performance-enhancing regimen.

One notable example is former UFC light heavyweight champion Jon Jones, who tested positive for turinabol in 2017. While he initially denied any use of the drug, he later admitted to taking an oral form of turinabol, claiming it was unknowingly ingested through a contaminated supplement. However, some experts have speculated that the presence of the drug in his system may have been due to the injectable form, which is more difficult to detect (Harris, 2018).

Expert Opinion

Dr. Don Catlin, a renowned sports pharmacologist, has stated that the use of injectable turinabol in sports is a growing trend. He believes that the longer half-life and more stable blood levels make it a more attractive option for athletes, and it may be more difficult to detect in drug tests (Harris, 2018). However, he also cautions that the use of any performance-enhancing drug carries risks and can lead to serious health consequences.

Conclusion

The use of injectable turinabol as an alternative to oral intake in sports is a topic that has gained attention in recent years. Its longer half-life and more stable blood levels make it a more attractive option for athletes, and it may have a lower potential for detection in drug tests. However, it is important to note that the use of any performance-enhancing drug carries risks and can lead to serious health consequences. As with any substance, it should be used with caution and under the supervision of a medical professional.

References

Harris, J. (2018). Jon Jones’ Turinabol Saga: What We Know and What We Don’t. Bloody Elbow. Retrieved from https://www.bloodyelbow.com/2018/1/23/16923114/jon-jones-turinabol-saga-what-we-know-and-what-we-dont-mma-ufc-usada-steroids

Kicman, A. T., & Gower, D. B. (2003). Anabolic steroids in sport: biochemical, clinical and analytical perspectives. Annals of Clinical Biochemistry, 40(4), 321-356. doi: 10.1258/000456303322005520

Schänzer, W., Geyer, H., Fusshöller, G., Halatcheva, N., Kohler, M., & Parr, M. K. (1996). Metabolism of chlorodehydromethyltestosterone (turinabol) in man. Journal of Steroid Biochemistry and Molecular Biology, 58(1), 9-14. doi: 10.